Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta

Non-invasive tests (NIT) for clinically significant portal hypertension (CSPH) in compensated advanced chronic liver disease (cACLD) lack validation in patients infected with hepatitis D virus (HDV).

Source: Journal of Hepatology - March 11, 2024 Category: Gastroenterology Authors: Mathias JACHS, Lisa SANDMANN, Lukas HARTL, Tammo TERGAST, Michael SCHWARZ, David Josef Maria BAUER, Lorenz BALCAR, Alena EHRENBAUER, Benedikt Silvester HOFER, Markus CORNBERG, Henrike LENZEN, Katja DETERDING, Michael TRAUNER, Mattias MANDORFER, Heiner WED Tags: Research Article Source Type: research